Nationwide Fund Advisors’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-100,534	Closed	-$3.77M	–	1506
2017 Q3	$3.77M	Buy	100,534 +33,734	+51%	+$1.36M	0.01%	1149
2017 Q2	$3.19M	Buy	66,800 +10,610	+19%	+$492K	0.01%	1228
2017 Q1	$2.56M	Buy	56,190 +33,482	+147%	+$1.45M	0.01%	1297
2016 Q4	$733K	Sell	22,708 -1,108	-5%	-$37K	﹤0.01%	1952
2016 Q3	$815K	Hold	23,816	–	–	﹤0.01%	1907
2016 Q2	$803K	Buy	23,816 +224	+0.9%	+$11K	﹤0.01%	1873
2016 Q1	$1.27M	Sell	23,592 -10,474	-31%	-$613K	0.01%	1579
2015 Q4	$2.62M	Sell	34,066 -27,044	-44%	-$1.53M	0.01%	1237
2015 Q3	$2.51M	Buy	61,110 +37,500	+159%	+$2.3M	0.01%	1253
2015 Q2	$1.67M	Sell	23,610 -12,425	-34%	-$979K	0.01%	1550
2015 Q1	$3.2M	Sell	36,035 -11,202	-24%	-$1.14M	0.01%	1214
2014 Q4	$4.19M	Sell	47,237 -6,109	-11%	-$578K	0.02%	1037
2014 Q3	$5.17M	Sell	53,346 -399	-0.7%	-$38.8K	0.02%	932
2014 Q2	$4.94M	Buy	53,745 +8,076	+18%	+$615K	0.02%	977
2014 Q1	$3.2M	Buy	45,669 +24,346	+114%	+$1.66M	0.01%	1097
2013 Q4	$1.23M	Sell	21,323 -604	-3%	-$31.8K	0.01%	1757
2013 Q3	$1.05M	Buy	21,927 +4,960	+29%	+$181K	﹤0.01%	1822
2013 Q2	$492K	Buy	+16,967	New	+$491K	﹤0.01%	2021